Cover Image

Immunocytochemical Expression of BAX and BAK Proteins in Cervical Smears of Women Positive for HPV Types: A Study of 120 Cases

Eirini Klapsinou, Elena Argyri, Efstathia Panotopoulou, Dimitra Daskalopoulou, Efstratios Patsouris, Afroditi Nonni, Andreas C Lazaris, Georgia-Heleni Thomopoulou

Abstract


Objective: Human Papillomavirus (HPV) infection is clearly associated with cervical cancer development. However, only a very small percentage of HPV-infected women will eventually develop cancer and the factors determining that progression have not yet been sufficiently clarified. It is known that HPV oncoproteins E6 and E7 interact with various squamous cell molecules towards promoting cell immortalization and carcinogenesis. Among these molecules are the proapoptotic proteins Bax and Bak, two key regulators of the intrinsic apoptotic pathway. The aim of this study is to test for possible statistically significant differences in the Bax and Bak expression in the Pap smears of HPV-positive and HPV-negative women and thus examine their potential value as prognostic markers.

Methods: One hundred and twenty women were subtyped for HPV using microarrays hybridization and then Bax and Bak expression was assessed using immunocytochemistry staining on cytocentrifuged ThinPrep samples.

Results: Statistical analysis determined that there was no statistically significant difference between the expression of Bax and Bak in the HPV-positive and HPV-negative women as this expression was detected by immunocytochemical assessment of ThinPrep samples.

Conclusion: Although in several published studies there is evidence of HPV oncoproteins affecting the expression of Bax and Bak on squamous cells, our study indicates that this effect is not apparent by immunocytochemical protein staining.


Keywords


Bax; Bak; cytology; cervical smears

References


Pavlidou E, Zafrakas M, Papadakis N Benos A, Agorastos T. Cervical, uterine corpus, and ovarian cancer mortality in Greece during 1980 to 2005: a trend analysis. Int J Gynecol Cancer. 2010, 20:482-487

Shai A, Pitot HC, Lambert PF. E6-associated protein is required for human papillomavirus type 16 E6 to cause cervical cancer in mice. Cancer Res. 2010, 70:5064-5073

Iavazzo C, Efthimiou D, Valavanis C, Leontara J, Zarganis P, Vorgias G. Late diagnosis of a neglected cervical carcinoma in an elderly woman: a case report. Med Gen Med. 2006, 8:20

Snijders PJ, Steenbergen RD, Heideman DA Meijer CJ. HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol. 2006, 208: 152-164

Muñoz N, Castellsagué X, de González AB Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine. 2006, 24:S3/1-10

Kroupis C, Thomopoulou G, Papathomas TG Vourlidis N, Lazaris AC. Population-based study of human papillomavirus infection and cervical neoplasia in Athens, Greece. Epidemiol Infect. 2007, 135:943-850

Tsiodras S, Hatzakis A, Spathis A, Margari N, Meristoudis C, Chranioti A, Kyrgiou M, Panayiotides J, Kassanos D, Petrikkos G, Nasioutziki M, Loufopoulos A, Paraskevaidis E, Karakitsos P. Molecular epidemiology of HPV infection using a clinical array methodology in 2952 women in Greece. Clin Microbiol Infect. 2011, 17:1185-1188

Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006, 118:3030-3044

Lichtig H, Algrisi M, Botzer LE, Abadi T, Verbitzky Y, Jackman A, Tommasino M, Zehbe I, Sherman L. HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6. Virology. 2006, 350: 216-227

Melar-New M, Laimins LA. Human Papillomaviruses Modulate Expression of MicroRNA 203 upon Epithelial Differentiation to Control Levels of p63 Proteins. J Virol. 2010, 84:5212-5221

Oh JM, Kim SH, Cho EA, Song YS, Kim WH, Juhnn YS. Human papillomavirus type 16 E5 protein inhibits hydrogen peroxide-induced apoptosis by stimulating ubiquitin–proteasome-mediated degradation of Bax in human cervical cancer cells. Carcinogenesis. 2010, 31:402-410

Liu HC, Chen GG, Vlantis AC, Tse GM, Chan ATC, van Hasselt CA. Inhibition of Apoptosis in Human Laryngeal Cancer Cells by E6 and E7 Oncoproteins of Human Papillomavirus 16. J Cell Biochem. 2008, 103:1125-1143

Thomas M, Banks L. Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types. J Gen Virol. 1999, 80:1513-1517

Simmonds M, Storey A. Identification of the regions of the HPV 5 E6 protein involved in Bak degradation and inhibition of apoptosis. Int J Cancer. 2008, 123:2260-2266

Dejean LM, Martinez-Caballero S, Manon S, Kinnally KW. Regulation of the mitochondrial apoptosis-induced channel, MAC, by BCL-2 family proteins. Biochim Biophys Acta. 2006, 1762: 191-201

Gross A, Jockel J, Wei MC, Korsmeyer SJ. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 1998, 17:3878-3885

Cellular adaptations, cell injury and cell death in: Kumar V, Abbas AK, Fausto N, eds. Robbins and Cotran Pathologic Basis of Disease. Philadelphia: Elsevier Saunders; p. 28-31.2005:

Valentijn AJ, Upton JP, Gilmore AP. Analysis of endogenous Bax complexes during apoptosis using blue native PAGE - implications for Bax activation and oligomerisation. Biochem J. 2008, 412: 347-357

Thomas M, Banks L. Inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene. 1998, 17: 2943-2954

Vogt M, Butz K, Dymalla S, Semzow J, Hoppe-Seyler F. Inhibition of Bax activity is crucial for the antiapoptotic function of the human papillomavirus E6 oncoprotein. Oncogene. 2006, 25:4009-4015

Shnittman-Magal S, Jackman A, Ish-Shalom S, Botzer LE, Gonen P, Schlegel R, Sherman L. Downregulation of Bax mRNA expression and protein stability by the E6 protein of human papillomavirus 16. J Gen Viro.l 2005, 86: 611-621

Krajewska M, Krajewski S, Epstein JI, Shabaik A, Sauvageot, J, Song K, Kitada S, Reed JC. Immunohistochemical Analysis of bcl-2, bax, bcl-X, and mcl-1 Expression in Prostate Cancers. Am J Pathol. 1996, 148:1567-1576

Rubio J, Ramos D, López-Guerrero JA, Iborra I, Collado A, Solsona E, Almenar S, Llombart-Bosch A. Immunohistochemical expression of Ki-67 antigen, cox-2 and Bax/Bcl-2 in prostate cancer; prognostic value in biopsies and radical prostatectomy specimens. Eur Urol. 2005, 48:745-751

Batinac T, Zamolo G, Hadzisejdić I, Zauhar G, Brumini G, Ruzić A, Persić V. Expression of Bcl-2 family proteins in psoriasis. Croat Med J. 2007, 48:319-326

Wortham NC, Alam NA, Barclay E, Pollard PJ, Wagner BE, Manek S, Elia G, Tomlinson IP. Aberrant expression of apoptosis proteins and ultrastructural aberrations in uterine leiomyomas from patients with hereditary leiomyomatosis and renal cell carcinoma. Fertil Steril. 2006, 86:961-971

D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007, 356: 1944-1956

Gillison ML. Human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: implications for clinical research in head and neck cancers. J Clin Oncol. 2006, 24: 5623-5625

Gillison ML, Shah KV. Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr Opin Oncol. 2001, 13:183-188

Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000, 92: 709-720

Delehedde M, Cho SH, Sarkiss M, Brisbay S, Davies M, El-Naggar AK, McDonnell TJ. Altered expression of bcl-2 family member proteins in nonmelanoma skin cancer. Cancer. 1999, 85:1514-1522

Loro LL, Johannessen AC, Vintermyr OK. Decreased expression of bcl-2 in moderate and severe oral epithelia dysplasias. Oral Oncol. 2002, 38:691-698

Erkek E, Bozdoğan O, Atasoy P, Birol A, Koçak M. BCL-2–Related Apoptosis Markers in Cutaneous Human Papillomavirus-Associated Lesions. Am J Dermatopathol. 2004, 26:113-118

Kokawa K, Shikone T, Otani T Nakano R. Apoptosis and the expression of Bax and Bcl-2 in squamous cell carcinoma and adenocarcinoma of the uterine cervix. Cancer. 1999, 85:1799-1809

Tjalma WA, Weyler JJ, Bogers JJ, Pollefliet C, Baay M, Goovaerts GC, Vermorken JB, van Dam PA, van Marck EA, Buytaert PM. The importance of biological factors (bcl-2, bax, p53, PCNA, MI, HPV and angiogenesis) in invasive cervical cancer. Eur J Obstet Gynecol Reprod Biol. 2001, 97:223-230

Cheah PL, Looi LM. Significance of Bcl-2 and Bax proteins in cervical carcinogenesis: an immunohistochemical study in squamous cell carcinoma and squamous intraepithelial lesions. Malays J Pathol. 2006, 28:1-5

Cheung TH, Chung TK, Lo KW, Yu MY, Krajewski S, Reed JC, Wong YF. Apotosis-related proteins in cervical intraepithelial neoplasia and squamous cell carcinoma of the cervix. Gynecol Oncol. 2002, 86:14-18

Jackson S, Hardwood C, Thomas M, Banks L, Storey A. Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev. 2000, 14:3065-3073

Du J, Chen GG, Vlantis AC, Chan PKS, Tsang RKY, van Hasselt CA. Resistance to apoptosis of HPV 16-infected laryngeal cancer cells is associated with decreased Bak and increased Bcl-2 expression. Cancer Letters. 2004, 205: 81-88

Underbrink MP, Howie HL, Bedard KM, Koop JI, Galloway DA. E6 Proteins from Multiple Human Betapapillomavirus Types Degrade Bak and Protect Keratinocytes from Apoptosis after UVB Irradiation. J Virol. 2008, 82:10408-10417

Struijk L, van der Meijden E, Kazem S, ter Schegget J, de Gruijl FR, Steenbergen RD, Feltkamp MC. Specific betapapillomaviruses associated with squamous cell carcinoma of the skin inhibit UVB-induced apoptosis of primary human keratinocytes. J Gen Virol. 2008, 89:2303-2314

Mo B, Pater A. Apoptosis, 5-fluorouracil sensitivity and expression of apoptotic proteins in a human ectocervical cell carcinogenesis model using different media. Eur J Pharmacol. 2003 , 467:15-22

Padilla LA, Leung BS, Carson LF. Evidence of an association between human papillomavirus and impaired chemotherapy-induced apoptosis in cervical cancer cells. Gynecol Oncol. 2002, 85:59-66

Sultana H, Kigawa J, Kanamori Y, Itamochi H, Oishi T, Sato S, Kamazawa S, Ohwada M, Suzuki M, Terakawa N. Chemosensitivity and p53–Bax pathway-mediated apoptosis in patients with uterine cervical cancer. Ann Oncol. 2003, 14: 214-219

Pim D, Tomaic V, Banks L. The human papillomavirus (HPV) E6* proteins from high-risk, mucosal HPVs can direct degradation of cellular proteins in the absence of full-length E6 protein. J Virol. 2009, 83:9863-74

Asadurian Y, Kurilin H, Lichtig H, Jackman A, Gonen P, Tommasino M, Zehbe I, Sherman L. Activities of human papillomavirus 16 E6 natural variants in human keratinocytes. J Med Virol. 2007, 79:1751-1760

Onwuegbuzie AJ, Leech NL. Post hoc power: A concept whose time has come. Understanding Statistics. 2004, 3:201-230


Full Text: PDF

Refbacks

  • There are currently no refbacks.


AJHP Copyright © 2012-2017. All rights reserved. Published by Ivy Union Publishing, 3204 Valley Rush Dr, Apex, North Carolina 27502, United States